Our Investor Relations Center is provided to give you convenient access to company information, including financial reports, press releases and corporate events. You can also sign up to be reminded via email of any upcoming company presentations, or to be notified of news releases and other announcements. If you cannot find the information you're looking for on our website please let us know, and we will do our best to accommodate your request.
Featured Report   2007 Form 10K Receive E-mail Alerts Alerts are e-mailed to you whenever certain new company information is posted to this site. Sign-up Now!		Stock Quote AMLN (Common) Exchange NASDAQ (US Dollar) Price $12.30 Change (%)   1.38 (10.09%) Volume 5,786,294 Data as of 10/10/08 4:00 p.m. ET Minimum 20 minute delay Refresh quote
Recent News More >> Date Title   10/01/08 Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 09/10/08 First Reported Head-to-Head Study Showed BYETTA® (exenatide) Injection Provided Greater Reduction in Post-Meal Glucose Levels Than Januvia™ (sitagliptin) in Patients With Type 2 Diabetes 08/28/08 Amylin Pharmaceuticals to Present at Thomas Weisel Healthcare, BioCentury NewsMakers, and Morgan Stanley Global Healthcare Conferences 08/26/08 Amylin Pharmaceuticals and Eli Lilly Provide Context for FDA Alert for BYETTA Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.